Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...

Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!

The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Ecnoglutide is distinguished by its selective activation of the cAMP signalling pathway, reducing β-arrestin recruitment.

Rachel Newton adopted her cat, Kramer, in 2020, but in early 2026, he was diagnosed with diabetes after showing symptoms like ...

Insulet said results from its study of a fully closed-loop automated insulin delivery system for type 2 diabetes shows an improvement over standard injection therapy. Insulet said its system showed 68 ...

Ozempic is a popular injectable medication that has gained attention worldwide, especially for managing type 2 diabetes and aiding weight loss. Its active ingredient, semaglutide, belongs to a class ...

The upcoming patent expiry for Ozempic in India is set to dramatically lower the cost of semaglutide, making this once-premium diabetes and weight-loss drug accessible to more patients. This shift ...

Type 1 diabetes, which is the most common type of diabetes in children, is an autoimmune disease. The body’s immune system attacks the insulin-producing cells in the pancreas. This process is very ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

India faces rising severe obesity. Experts discuss how GLP-1 and dual GIP/GLP-1 medications, combined with lifestyle and ...

Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.